Southlake, TX — Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease, today announced that it has signed a distribution agreement with FJ Medical, Denmark.
FJ Medical has been appointed as HeartSciences' distributor for the MyoVista wavECG™ and related supplies for the Nordic countries of Denmark, Sweden, Norway and Finland. FJ Medical has more than 23 years of experience selling cardiac imaging and screening equipment in the Nordic region and is based in Denmark. The agreement requires stocking MyoVista devices and supplies, and distributors are also required to provide prompt technical service to customers in the region.
"We have been undertaking numerous evaluation and physician engagement activities in Denmark and the appointment of FJ Medical will help us leverage these relationships as we prepare for commercialization," said Andrew Simpson, CEO of HeartSciences.
Investor contact
Mark Komonoski, Integrous Communications · 877-255-8483 · [email protected]